Solve Therapeutics
Biotechnology company developing next-generation antibody-drug conjugates (ADCs) and targeted therapeutics for cancer treatment.
Location
Boston, Massachusetts, USA
Founded
2020
Investors
1
Categories
biotech, therapeutics, oncology, antibody-drug-conjugate
Notes
Solve Therapeutics is a biotechnology company focused on developing next-generation therapeutics for cancer treatment. The company is working on antibody-drug conjugates (ADCs) and other targeted therapeutic modalities.
ADCs combine the targeting specificity of antibodies with the cell-killing potency of cytotoxic drugs, enabling more precise delivery of cancer-killing payloads to tumor cells while minimizing damage to healthy tissue.
Team
- Leadership team information not publicly disclosed
Additional Research Findings
- Oncology therapeutics focus
- Antibody-drug conjugate development
- Boston, Massachusetts headquarters
- Next-generation cancer treatments
- Founded in 2020
Sources
Investors
| Name | Location | Type | Stages | Portfolio |
|---|---|---|---|---|
| Abingworth | London, UK / Boston, USA | biotech-focused | seedseries-a+3 | 34 |